Advertisement
News
Advertisement

FDA Cleared ChromaGen Lenses Are A Life-Changing Aid For People Struggling With Dyslexia And Other Reading Problems

Wed, 03/27/2013 - 3:30pm
PR Newswire

KENNETT SQUARE, Pa., March 27, 2013 /PRNewswire/ -- Words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or double sentences, re-reading the same lines - these are some of the reading difficulties that students at the Brighton School recently described. These symptoms can cause headaches, nausea, and fatigue, loss of concentration and even avoidance of reading all together. Now there is hope with the new, patented and FDA cleared ChromaGen lenses. These lenses are a life changing aid for people with dyslexia and other reading disorders.

The ChromaGen lenses were developed by Dr. David Harris , who has concluded after years of studying dyslexia the majority of people who have dyslexia see words that appear to be moving on the page in some way.

"Approximately 90 percent of these people who see words moving will benefit from ChromaGen lenses," said Harris, who has a PhD in Neurological Implications and Assistance for Reading Disability from Marylebone University in London. "Individuals that use ChromaGen lenses will experience instantaneous symptom relief. The patient will see an immediate improvement in reading speed, comprehension and even an improvement in handwriting."

"When I saw our students being tested, I saw immediate positive responses," said Kenneth Payne , Principal and Executive Director for Brighton School. "I heard students saying things like I'm seeing better, the words aren't jumping off the page, the lines aren't running together, things are clearer and if that is happening then it will definitely have a positive effect on their reading. These lenses can make a big difference in the lives of many of our students."  

Please follow this link to view a video documenting the ChromaGen screening at Brighton School http://youtu.be/Vctz3TsMhhQ.

ChromaGen technology is an optical treatment option that employs sixteen different filtered lenses. The lenses modify lights' wavelength as it passes into each eye, which dynamically balances the speed of the information traveling along the neurological pathways to the brain. The result is that people are now seeing words and text that are clear and in focus and enjoy reading free of headaches, nausea and fatigue.

Dr. Edward Huggett , D.O. and Chief Optometric Advisor for ChromaGen Vision, LLC says, "I am prescribing the ChromaGen technology because it provides relief for those patients who have experienced 'word movement' while reading for so long that they have lost hope. Now these chronic sufferers have options."

Huggett, who specializes in the treatment of low vision and binocular vision, is the founder and director of the Low Vision clinic at St. Luke's Cataract & Laser Institute in Tarpon Springs, Florida and the Children's Specialty Vision Clinic in Dunedin, Florida.

ChromaGen lenses are available through a nationwide network of specially trained optometrists or ophthalmologists. Each eye is tested separately to find the best combination of lenses for the patient. The results are instantaneous and the patients will know immediately before leaving the doctor's office if ChromaGen is an effective solution for them. ChromaGen lenses come with a 100 percent money back guarantee.

"I wish that we would have had this technology to offer these students a lot earlier," said Payne, "The difference in their reading performance before and after being fitted with the ChromaGen lenses was almost unbelievable."

Available as eyeglasses, contact lenses and clip-ons, ChromaGen has been cleared by the U.S. Food and Drug Administration (FDA) and are patented. To learn more about ChromaGen or find a Doctor in your area, visit www.IReadBetterNow.com.  For media or news information, visitwww.ChromaGenPressKit.com.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading